Form 4: Aspira Women's Health Director Exercises Restricted Stock Units
SEC Form 4
Director John Phillip Ragard converted 4,843 restricted stock units into common stock of Aspira Women's Health Inc. on March 31, 2025.
Summary
- On March 31, 2025, John Phillip Ragard, a director of Aspira Women's Health Inc., converted 4,843 restricted stock units (RSUs) into common stock.
- This transaction was reported on a Form 4 filed with the SEC on April 1, 2025.
- Following the transaction, Ragard directly owns 4,844 derivative securities and 129,890 shares of common stock.
- The RSUs were granted on August 22, 2024, with a portion vesting on March 31, 2025.
Sentiment
Score: 5
Explanation: This is a neutral reporting of a standard transaction related to executive compensation.
Industry Context
This is a routine disclosure related to executive compensation and stock ownership, common in publicly traded companies.
Stakeholder Impact
- The transaction has a minor dilutive effect on existing shareholders due to the issuance of new shares.
Key Dates
| Date | Description |
|---|---|
| 08/22/2024 | Reporting person was granted 19,375 RSUs |
| 08/26/2024 | RSUs were previously reported in Table II on a Form 4 filed with the SEC |
| 03/31/2025 | 4,843 RSUs vested and were converted into common stock |
| 04/01/2025 | Form 4 filed with the SEC reporting the transaction |
Keywords
Aspira Women's Health, Director, John Phillip Ragard, Restricted Stock Units, RSUs, Common Stock, Form 4, SEC, Beneficial Ownership, Vesting
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.